We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.82%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$44.6B
AUM Growth
+$2.78B
(+6.7%)
Cap. Flow
+$458M
Cap. Flow
% of AUM
1.03%
Top 10 Holdings %
Top 10 Hldgs %
21.42%
Holding
1,095
New
123
Increased
256
Reduced
361
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$266M |
| 2 |
Johnson Controls International
JCI
|
+$236M |
| 3 |
Dover
DOV
|
+$181M |
| 4 |
lululemon athletica
LULU
|
+$158M |
| 5 |
KeyCorp
KEY
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIVB
SVB Financial Group
SIVB
|
+$172M |
| 2 |
GE Aerospace
GE
|
+$120M |
| 3 |
Fortive
FTV
|
+$113M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$105M |
| 5 |
MetLife
MET
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.96% |
| 2 | Healthcare | 17.3% |
| 3 | Financials | 12.89% |
| 4 | Industrials | 9.84% |
| 5 | Consumer Discretionary | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RETA
251
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $42.7M | 0.1% |
469,618
-836,235
| -64% | -$49.1M |
|
252
Healthcare Realty
HR
$6.92B
| $41.6M | 0.09% |
2,150,000
+1,425,000
| +197% | +$28.7M |
|
253
Idexx Laboratories
IDXX
$46.5B
| $41.5M | 0.09% |
82,901
-1,300
| -2% | -$622K |
|
254
Ovintiv
OVV
$16.6B
| $41.3M | 0.09% |
1,144,949
-840,000
| -42% | -$37.1M |
|
255
Ecolab
ECL
$79.5B
| $41.1M | 0.09% |
248,125
-3,900
| -2% | -$608K |
|
|
NVO
256
Novo Nordisk
NVO
$203B
| $41M | 0.09% |
515,618
-192,754
| -27% | -$13.7M |
|
257
Agilent Technologies
A
$39.9B
| $41M | 0.09% |
296,294
-4,800
| -2% | -$702K |
|
258
Adient
ADNT
$1.45B
| $41M | 0.09% |
1,000,000
+500,000
| +100% | +$20.9M |
|
259
Estee Lauder
EL
$30.9B
| $40.4M | 0.09% |
163,984
-61,200
| -27% | -$15.5M |
|
260
Pool Corp
POOL
$7.31B
| $40.4M | 0.09% |
117,923
+4,400
| +4% | +$1.56M |
|
261
Middleby
MIDD
$6.03B
| $40.2M | 0.09% |
+274,000
| New | +$40.7M |
|
262
Autodesk
ADSK
$51.2B
| $39.8M | 0.09% |
191,089
+11,500
| +6% | +$2.37M |
|
263
Patria Investments
PAX
$1.81B
| $39.5M | 0.09% |
2,667,993
-129,135
| -5% | -$1.97M |
|
|
KDNY
264
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $39.4M | 0.09% |
1,704,000
+883,822
| +108% | +$21.1M |
|
265
Nucor
NUE
$61.9B
| $39.1M | 0.09% |
253,300
-7,600
| -3% | -$1.21M |
|
266
AES
AES
$10.5B
| $39M | 0.09% |
1,618,812
+939,400
| +138% | +$23.9M |
|
267
BioXcel Therapeutics
BTAI
$25.6M
| $38.8M | 0.09% |
130,124
+75,436
| +138% | +$32.2M |
|
268
Realty Income
O
$59B
| $38.8M | 0.09% |
613,000
-149,900
| -20% | -$9.71M |
|
269
Dow Inc
DOW
$21.9B
| $38.7M | 0.09% |
705,800
-10,000
| -1% | -$563K |
|
270
Pinnacle West Capital
PNW
$12.2B
| $38.7M | 0.09% |
488,283
-101,800
| -17% | -$7.68M |
|
271
GCM Grosvenor
GCMG
$814M
| $38.6M | 0.09% |
4,942,786
| – | – |
|
|
FLG
272
Flagstar Bank National Association
FLG
$5.9B
| $38.4M | 0.09% |
1,415,089
+189,912
| +16% | +$5.14M |
|
|
CBAY
273
DELISTED
Cymabay Therapeutics
CBAY
| $38.4M | 0.09% |
4,399,400
+3,899,400
| +780% | +$31.2M |
|
|
274
MetLife
MET
$63.7B
| $38.2M | 0.09% |
659,926
-1,510,400
| -70% | -$102M |
|
275
Dollar General
DG
$28.1B
| $37.7M | 0.08% |
178,900
-33,600
| -16% | -$7.54M |
|
Similar funds
Adage Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Adage Capital Partners held 1,095 positions worth $44.6B, up 6.7% from $41.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2023 filing shows 123 new, 256 increased, 361 reduced and 182 closed positions. Its largest new stake was Honeywell: 1,414,289 shares worth $255M. The largest sale was SVB Financial Group, an estimated $172M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2023 buy was Honeywell: 1,414,289 shares worth $255M.
- Adage Capital Partners added most to Johnson Controls International in Q1 2023, an estimated $236M increase.
- Adage Capital Partners's biggest Q1 2023 reduction was Fortive, cutting an estimated $113M.
- Adage Capital Partners fully exited SVB Financial Group in Q1 2023, selling an estimated $172M.
- Adage Capital Partners's ten largest holdings make up 21% of its $44.6B portfolio in Q1 2023.
- Adage Capital Partners opened 123 new positions and closed 182 in Q1 2023.
- Adage Capital Partners's portfolio value rose 6.7% quarter-over-quarter to $44.6B.
Based on Adage Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.